FORM 6

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a - 16 or 15d - 16 of

the Securities Exchange Act of 1934

 

For the month of June, 2003

Commission File Number: 1-10817

 

CELLTECH GROUP PLC

(Translation of registrant's name into English)

 

208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F X      Form 40-F

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes          No X

 

(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).

 

 

Enclosure: Holding(s) in Company released 13 June, 2003

 

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Name of company

Celltech Group plc

2. Name of shareholder having a major interest

The Capital Group Companies, Inc. on behalf of its affiliates, including Capital Research and Management Company, Capital International S.A., Capital International, Inc., Capital Guardian Trust Company and Capital International Limited

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18

As in 2 above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them

State Street Nominees Limited

3,500

Bank of New York Nominees

34,100

Chase Nominees Limited

2,244,003

Citibank London

106,100

Nortrust Nominees

1,030,000

Mellon Nominees (UK) Limited

80,600

State Street Nominees Limited

306,700

Bank of New York Nominees

5,823,799

Northern Trust

1,454,502

Chase Nominees Limited

2,494,663

Midland Bank plc

168,500

Bankers Trust

2,328, 400

Barclays Bank

60,000

Citibank London

53,000

Morgan Guaranty

324,300

Nortrust Nominees

2,834,106

State Street Bank & Trust Co.

179,600

Deutsche Bank AG

904,300

HSBC Bank plc

1,222,000

Mellon Bank N.A.

230,300

Northern Trust AVFC

196,436

KAS UK

64,810

Mellon Nominees (UK) Limited

63,500

Bank One London

103,200

State Street Nominees Limited

58,000

Bank of New York Nominees

82,000

Chase Nominees Limited

1,887,500

Midland Bank plc

19,500

Barclays Bank

394,300

Brown Bros.

34,100

Royal Bank of Scotland

1,223,900

State Street Bank & Trust Co.

80,400

Lloyds Bank

87,700

Vidacos Nominees Ltd

100,000

RBSTB Nominees Ltd

133,300

Citibank NA

17,600

HSBC Bank plc

362,000

State Street Nominees Limited

1,135,059

Bank of New York Nominees

194,300

Chase Nominees Limited

830,000

Midland Bank plc

110,100

Deutsche Bank Mannheim

31,000

Bankers Trust

17,377

Citibank London

45,900

Nortrust Nominees

613,800

Royal Bank of Scotland

82,500

State Street Bank & Trust Co.

256,499

RBSTB Nominees Ltd

18,400

Citibank NA

98,400

Deutsche Bank AG

31,200

Chase Manhattan Nominee Ltd

5,300

HSBC Bank plc

113,400

State Street Nominees Limited

2,979,054

5. Number of shares / amount of stock acquired

165,703 (since last notification)

6. Percentage of issued class

0.05%

7. Number of shares / amount of stock disposed

N/A

8. Percentage of issued class

N/A

9. Class of security

50p Ordinary Shares

10. Date of transaction

11 June 2003

 

 

11. Date company informed

13 June 2003

12. Total holding following this notification

33,353,008

13. Total percentage holding of issued class following this notification

12.016%

14. Any additional information

 

 

15. Name of contact and telephone number for queries

Cheryl Cramer Tel. 01753 447933

16. Name and signature of authorised company official responsible for making this notification

J A D Slater

Date of notification

13 June 2003

The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material.

END

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

                                                                                                                                                           CELLTECH GROUP PLC
                                                                                                                                                           (Registrant)

 

 

                                                                                                                                                           By: /s/ PETER ALLEN       
                                                                                                                                                           Peter Allen
                                                                                                                                                           Chief Financial Officer

 

Dated: 13 June, 2003